Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amkay ProductsBOM:544169 37 Days Payable is 34.79 as of Mar. 2026, which is 30% below its 10-year median of 50.01. GuruFocus rates BOM:544169 with a GF Score™ of 37/100. The stock has 2 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Amkay Products ranks worse than 81.74% on this metric.
The historical rank and industry rank for Amkay Products's Days Payable or its related term are showing as below:
BOM:544169'
s Days Payable Range Over the Past 10 Years
Min: 31.44 Med: 50.01 Max: 75.16
Current: 32.45
During the past 6 years, Amkay Products's highest Days Payable was 75.16. The lowest was 31.44. And the median was 50.01.
BOM:544169's Days Payable is ranked worse than 81.74% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.615
vs BOM:544169: 32.45
Amkay Products's Days Payable
declined
from Mar. 2025 (36.82) to Mar. 2026 (34.79).
It may suggest that Amkay Productsaccelerated paying its suppliers.
The historical data trend for Amkay Products's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544169 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Amkay Products's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amkay Products Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Amkay Products's Days Payable distribution charts can be found below:
* The bar in red indicates where Amkay Products's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Amkay Products's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amkay Products (BOM:544169) has a Days Payable of 34.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amkay Products and its competitors. This is 30% below median its historical median of 50.01. Over the past decade, Amkay Products' Days Payable has ranged from 31.44 to 75.16. According to the industry distribution chart, Amkay Products ranks #649 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 81.7%.
Is Amkay Products' Days Payable too high?
Amkay Products' current Days Payable of 34.79 is 30% below median its 10-year median of 50.01. Over the past 10 years, this metric has ranged from a low of 31.44 to a high of 75.16. The Medical Devices & Instruments industry median Days Payable is 68.62. Amkay Products' value of 34.79 is 49.3% below this industry median. Based on the distribution chart, Amkay Products ranks #649 out of 794 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Amkay Products has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Amkay Products' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Amkay Products ranks #649 out of 794 companies for Days Payable. This places Amkay Products in the lower half of its industry. The industry median Days Payable is 68.62. Amkay Products' value of 34.79 is 49.3% below this benchmark. Historically, Amkay Products' own Days Payable has ranged from 31.44 to 75.16 over the past decade. While the company's 10-year median is 50.01 vs. the industry median of 68.62, Amkay Products has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amkay Products's current Days Payable of 34.79 is 49.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Amkay Products and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amkay Products's current Days Payable is 34.79, which is 30% below median its own 10-year median of 50.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amkay Products stock overvalued right now?
Amkay Products (BOM:544169) has a current Days Payable of 34.79. The current Days Payable is 34.79, which is 30% below median its 10-year median of 50.01 and 49.3% below the Medical Devices & Instruments industry median of 68.62. Amkay Products' overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Amkay Products (BOM:544169), the current Days Payable is 34.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amkay Products Ltd is a healthcare company. It manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centers, hospitals/clinics, nursing homes etc. Additionally, engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.
37GF Score
Get the complete analysis for BOM:544169
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544169 has been successfully added to your 
